Two Charged in Ozempic Counterfeit Drug Scheme by DOJ

Published on Β· Source: cnbc.com

Two Charged in Ozempic Counterfeit Drug Scheme by DOJ

AI Summary

Summarized by AI from the source below

Two Indian nationals, Swapnadip Roy and Vicky Ramancha, have been charged in Florida with smuggling counterfeit Ozempic from China. They face a maximum sentence of 71 years in prison if convicted. Allegations state that the smuggling scheme began in July 2023 and continued through April 2024. The Food and Drug Administration had previously seized counterfeit Ozempic drugs in 2023 and warned the public. This matter is significant for investors in Novo (NVO), as counterfeit drugs could harm the company's reputation and sales of its legitimate products.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.

Understand this kind of story

Get the weekly market brief

One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.

Β© 2026 NewsStocks.liveTermsPrivacy